Interview with Andrew J. Muir, M.D., M.H.S.

Integrating daclatasvir into hepatitis c therapy

Clinical Liver Disease (CLD), an official digital learning resource of The American Association for the Study of Liver Diseases is an interactive, up-to-date source of education, designed for physicians and healthcare providers caring for the patient with liver disease. CLD provides current and clinically relevant information through educational interventions every two months.

Share Integrating daclatasvir into hepatitis c therapy

Sign up to save your podcasts

Integrating daclatasvir into hepatitis c therapy

Integrating daclatasvir into hepatitis c therapy